Acompanhe as Notícias da Recifes

In a first-of-its-kind study by King's College London, researchers have linked changes in two major types of immune cells in blood to different survival outcomes for patients with melanoma.

Immunosuppressive medications help prevent organ rejection following transplantation, yet some patients still experience rejection despite receiving adequate treatment.

Researchers have shown that an imaging model can detect microstructural abnormalities in the brain associated with Huntington's disease, potentially offering a new method for monitoring disease progression and evaluating new treatments.

Questionnaires that track depression, anxiety and other symptoms can help psychiatrists determine whether a patient is improving. But incorporating those measures into routine care requires clinicians to know how to interpret the results and use them in treatment decisions.

Researchers from the American Academy of Pediatrics Committee on Infectious Diseases updated recommendations for the use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2026–2027 influenza season.

A new study from the University of California San Diego Rady School of Management suggests that when physicians try to reassure patients by saying their symptoms are "normal," patients may infer that treatment isn't necessary—and become less inclined to seek it. Doctors may think

HIV (human immunodeficiency virus) is a virus that attacks the body's immune system and remains a major global health challenge because of persistent viral reservoirs, despite effective treatments. Key factors include around 40 million people living with HIV, 1 million new infect

Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes (MDS), a discovery that could lead to more targeted treatments for this aggressive blood cance

A tumor is more than its cancer cells. Immune cells, blood vessels and other surrounding tissue influence how a cancer grows and responds to treatment. Two tumors containing the same cell types can respond very differently to the same therapy depending on how those cells are arra

New research from the University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, despite promising laboratory studies of intermittent

Dialysis is a lifesaving medical treatment for people whose kidneys can no longer efficiently filter waste, toxins and excess fluids from the blood.

A nationwide Veterans Affairs (VA) study comparing two leading treatments for metastatic prostate cancer may help doctors choose the right drug for each patient, said a Rutgers Cancer Institute physician-scientist whose invited editorial accompanies the research.